VLA 0.00% $1.75 viralytics limited

Ann: New Data at SITC Meeting. Further Studies Announced, page-86

  1. 1,172 Posts.
    lightbulb Created with Sketch. 71
    Hi GG,
    Specific question/s for the AGM:-

    "Cavatak has continually delivered excellent results and a superb safety profile either as a monotherapy or in combination.
    Pharmaceutical Companies will no doubt be totally aware of the clinical results.
    Has interest been shown?... if so, by whom?... to what extent?

    Thank you GG.... I look forward to reading your experience.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.